[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:aphakia":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":28,"states":29},"Aphakia",3,2,[8,15,21],{"nct_id":9,"title":10,"phases":11,"status":12,"updated_at":13,"content_modified":14},"NCT07502456","Clareon TruPlus Study",[],"RECRUITING","2026-08-03T03:26:04.638727Z","2026-05-05T02:43:27.597701Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT07147192","Feasibility Study of an Accommodating IOL Design",[],"2026-08-03T03:02:58.488119Z","2026-05-05T02:43:29.521511Z",{"nct_id":22,"title":23,"phases":24,"status":25,"updated_at":26,"content_modified":27},"NCT07347379","Long-Term Clinical Outcomes Of Subjects Enrolled In The RxSight Light Adjustable Lens (LAL) And Light Delivery Device (LDD) New Enrollment Study",[],"ENROLLING_BY_INVITATION","2026-08-03T02:19:01.379791Z","2026-06-16T05:54:07.879151Z",[],[]]